# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001453687-25-000050
Filing Date
2025-01-27
Accepted
2025-01-27 07:04:17
Documents
15
Period of Report
2025-01-27
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | rnac-20250127.htm iXBRL | 8-K | 30210
2 | EX-99.1 | pressrelease012725.htm | EX-99.1 | 15039
6 |  | cartesian_logoxcolorxcmyk.jpg | GRAPHIC | 1268513
| Complete submission text file | 0001453687-25-000050.txt |  | 1850609

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
3 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | rnac-20250127.xsd | EX-101.SCH | 1862
4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | rnac-20250127_lab.xml | EX-101.LAB | 21885
5 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | rnac-20250127_pre.xml | EX-101.PRE | 12572
17 | EXTRACTED XBRL INSTANCE DOCUMENT | rnac-20250127_htm.xml | XML | 2722

Mailing Address 7495 NEW HORIZON WAY FREDERICK MD 21703
Business Address 7495 NEW HORIZON WAY FREDERICK MD 21703 301-348-8698
Cartesian Therapeutics, Inc. (Filer) CIK: 0001453687 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37798 | Film No.: 25555744
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)